HPV-RELATED ANAL SQUAMOUS CELL CARCINOMA
Clinical trials for HPV-RELATED ANAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED ANAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED ANAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise against HPV-Driven cancers
Disease control OngoingThis study tests whether combining two drugs—TG4001 (a vaccine-like therapy) and avelumab (an immunotherapy)—can shrink tumors or slow disease in people with advanced HPV-16 cancers (cervical, anal, penile, vulvar, or vaginal). About 143 adults whose cancer has spread or returned…
Matched conditions: HPV-RELATED ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
Personalized T-Cell army takes on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new treatment called T-Plex for people with advanced solid tumors that have not responded to standard therapies. The treatment uses a patient's own immune cells, which are modified in a lab to recognize and attack multiple cancer-related targets. Th…
Matched conditions: HPV-RELATED ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC